Established risk factors and coronary artery disease: The framingham study

American Journal of Hypertension

Volumn 7, Issue 7, 1994, Pages 7S-12S

  Wilson, Peter W F ^a  

^a FRAMINGHAM HEART STUDY   (United States)

Author keywords

Coronary artery disease; Risk factors

Indexed keywords

ALCOHOL;

BLOOD PRESSURE; CIGARETTE SMOKING; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; HUMAN; LIPID BLOOD LEVEL; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

ALCOHOL DRINKING; BLOOD PRESSURE; CORONARY DISEASE; DIABETES MELLITUS; DIET; FIBRINOGEN; HUMAN; LEUKOCYTE COUNT; LIFE STYLE; LIPIDS; LONGITUDINAL STUDIES; OBESITY; RISK FACTORS; SMOKING;

EID: 0027994593     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/7.7.7S     Document Type: Article

References (47)

1. Stokes J III, Kannel WB, Wolf PA, et al: Blood pressure as a risk factor for cardiovascular disease. Hypertension 1989;13(suppl 1):13–18.
2. Keys A, Menotti A, Aravanis C: The Seven Countries Study: 2, 289 deaths in 15 years. Prev Med 1984;13:141–154.
3. Kannel WB, Wolf PA, Garrison RJ: Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up. Springfield, National Technical Information Service, 1987, pp 1–459.
4. Kannel WB: Risk factors in hypertension. J Cardiovasc Pharmacol 1989;13(suppl 1):4–10.
5. Abbott RD, Wilson PWF, Kannel WB, Castelli WP: High-density lipoprotein cholesterol, total cholesterol, and myocardial infarction: The Framingham Study. Arteriosclerosis 1988;8:207–211.
6. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project. J Chron Dis 1978;31:201–306.
7. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of CHD and cholesterol lowering. JAMA 1984;251:365–374.
8. Blankenhorn DH, Johnson RL, Mack WJ, et al: The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990;263:1646–1651.
9. Castelli WP, Garrison RJ, Wilson PWF, et al: Coronary heart disease incidence and lipoprotein cholesterol levels: The Framingham Study. JAMA 1986;256:2835–2838.
10. Miller GJ, Miller NE: Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;i:16–19.
11. Gordon DJ, Knoke J, Probstfield JL, et al: High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 1986; 74:1217–1225.
12. Manninen V, Elo O, Frick MH, et al: Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260:641–651.
13. Brown G, Albers JJ, Fisher LDM, et al: Regression of coronary artery disease as a result of intensive lipid- lowering therapy in men with high levels of apoli-poprotein B. N Engl J Med, 1990;323:1289–1298.
14. Hulley SB, Rosenman RH, Bawol RD, et al: Epidemiology as a guide to clinical decisions: The association between triglycerides and CHD. N Engl J Med 1980; 302:1383–1389.
15. Wilson PWF, Anderson KM, Castelli WP: The impact of triglycerides on coronary heart disease: the Framingham Study. Atheroscler Rev 1991;22:59–63.
16. Schaefer EJ, Genest JJ Jr, Ordovas JM, et al: Familial lipoprotein disorders and premature coronary artery disease. Curr Opin Lipid 1993;4:288–298.
17. Scanu AM, Scandiani L: Lipoprotein(a): Structure, biology and clinical relevance. Adv Intern Med 1991;36:249–270.
18. Bhatnagar D, Durrington PN: Does measurement of apolipoproteins add to the clinical diagnosis and management of dyslipidaemias? Curr Opin Lipid 1993;4:299–304.
19. Cambien F, Poirier O, Lecer L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1993;359:641–644.
20. Jeunemaitre X, Soubrier F, Kotelertsev YV, et al: Molecular basis of human hypertension: Role of angioten-sinogen. Cell 1992;71:169–180.
21. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968–977.
22. Manson JE, Colditz GA, Stampfer MJ, et al: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882–889.
23. Ducimetiere P, Richard J, Cambien F: The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: The Paris Prospective Study. Int J Obes 1986;10:229–240.
24. Donahue RP, Abbott RD, Bloom E, et al: Central obesity and coronary heart disease in men. Lancet 1987;i: 821–824.
25. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hy- perinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:702–706.
26. Krolewski AS, Kosinski EJ, Warram JH, et al: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750–755.
27. Wilson PWF, Kannel WB: Epidemiology of hyperglycemia and atherosclerosis, in Ruderman N, Williamson J, Brownlee M (eds): Hyperglycemia, Diabetes, and Vascular Disease. New York, Oxford University Press, 1992, pp 21–29.
28. Kannel WB, Wilson PWF, Blair SN: Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985;109:875–885.
29. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh C-C: Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605–613.
30. Dannenberg AL, Keller JB, Wilson PWF, Castelli WP: Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates. Am J Epidemiol 1989;129:76–87.
31. Blair SN, Kohl HW III, Paffenbarger RS Jr, et al: Physical fitness and all-cause mortality: A prospective study of healthy men and women. JAMA 1989;262: 2395–2401.
32. Abbott RD, Levy D, Kannel WB, et al: Cardiovascular risk factors and graded treadmill exercise endurance in healthy adults: The Framingham Offspring Study. Am J Cardiol 1989;63:342–346.
33. Hegsted DM, McGandy RB, Myers ML, Stare FJ: Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965;17:281–295.
34. Keys A: The Seven Countries Study: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, Harvard Press, 1980.
35. Gotto AM Jr, LaRosa JC, Hunninghake D, et al: The cholesterol facts: A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung and Blood Institute. Circulation 1990;81:1721–1733.
36. Salonen JT: The role of iron as a cardiovascular risk factor. Curr Opin Lipid 1993;4:277–282.
37. Gaziano JM, Hennekens CH: Vitamin antioxidants and cardiovascular disease. Curr Opin Lipid 1992;3: 291–294.
38. Manson JE, Tosteson H, Ridker PM, et al: The primary prevention of myocardial infarction. N Engl J Med 1992;326:1406–1416.
39. Ockene JK, Kuller LH, Svendsen KH, Meilahn E: The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFTT). Am J Publ Health 1990;80:954–958.
40. Castelli WP, Garrison RJ, Dawber TR, et al: The filter cigarette and coronary heart disease: The Framingham Study. Lancet 1981;ii:109–113.
41. Palmer JR, Rosenberg L, Shapiro SL: “Low-yield” cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 1989;320:1569–1573.
42. Boffetta P, Garfinkel L: Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990;1:342–348.
43. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (Part 1). N Engl J Med 1992;326:242–250.
44. Ridker PM: An epidemiologic assessment of thrombotic risk factors for cardiovascular disease. Curr Opin Lipid 1992;3:285–290.
45. Kannel WB, Anderson KM, Wilson PWF: White blood cell count and cardiovascular disease: Insights from the Framingham Study. JAMA 1992;267:1253–1256.
46. Meade TW, Brozovic M, Chakrabarti RR, et al: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986;ii:533–537.
47. Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:357–363.